B2B Biopack ApS: Financial statements 2019
CVR: 38800248
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
B2B Biopack ApS (CVR 38800248) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -105,774 and a net result of DKK -108,690. Equity in the 2019 report amounted to DKK 1,239,388. The solvency ratio was 85.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -105,774
- Profit/Loss
- DKK -108,690
- Equity
- DKK 1,239,388
- Total Assets
- DKK 1,451,199
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of December 20, 2019, Bo Lundqvist has left the board of directors of B2B Biopack ApS.
As of October 1, 2019, Preben Rasmussen has joined the board of directors of B2B Biopack ApS.
As of October 1, 2019, Mikkel Severin Larsen has joined the board of directors of B2B Biopack ApS.
As of October 1, 2019, Bo Lundqvist has joined the board of directors of B2B Biopack ApS.
B2B Biopack ApS has published its interim report for the period July 14, 2017 to December 31, 2018.
About B2B Biopack ApS
B2B Biopack ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2017. The company is under bankruptcy. The company is registered under the industry Engroshandel med andre råvarer og halvfabrikata. The company was previously named CMC Biopack ApS. The company is owned by CEMACL HOLDING ApS and JAHolding2020 ApS. The company has 2 employees (2025). In 2024, the company reported a gross profit of DKK 247,492 and a net result of DKK 88,557 compared with DKK -656,657 the year before. Equity in the 2024 report amounted to DKK -1,613,850.